Lars Backsell

All filings by Lars Backsell on record concern Recipharm AB. In total, 12 filings cover trades dated from 17 December 2018 to 17 February 2021.

The open-market side counts 2 purchases for €15.8M alongside 4 sales for €263.2M. The net balance comes to €247.5M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2021: no purchases and 2 sales on the market.

On 22 February 2021 came the latest disclosure, an open-market sale for €1.3M in Recipharm AB. The latest purchase dates back some time: it was published 2,882 days ago, on 17 December 2018. Typically, a trade is published a median of 2 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.